MOTS-c (Mitochondrial Peptide)

Why Mitochondrial Genetics Is Not Like Nuclear Genetics

UKPWritten and published by UK Peptides2 min readUpdated 3 cited sources

The short answer

Each cell contains many copies of the mitochondrial genome rather than the two copies of each nuclear gene. Copy number varies between tissues and individuals, and different copies can carry different sequences, a state called heteroplasmy.

Key facts

Nuclear genes
Two copies per cell
Mitochondrial genome
Many copies per cell
Heteroplasmy
Different copies, different sequences
Correlates with
Skeletal muscle oxidative capacity
Key study
Tian 2021, Aging Cell (PMID 34612579)
Measurement
P31 MR spectroscopy in that study

The structural difference

A nuclear gene comes in two copies, one per chromosome. Mitochondrial DNA does not work that way. Each mitochondrion carries several genomes and each cell carries many mitochondria, so copy number runs to hundreds or thousands and varies by tissue according to energy demand.

What heteroplasmy means

That the many copies need not be identical. A mutation arising in one genome is not corrected against a partner copy the way a nuclear mutation can be, so a cell can carry a mixture of variant and wild-type sequences in some proportion. That proportion is the heteroplasmy load, and it is a continuous quantity rather than a present-or-absent state.

Research material referenced

MOTS-C 10mg, third-party HPLC tested

Buy MOTS-C · £24.99

Why that produces threshold effects

A low proportion of a damaging variant is buffered by the remaining normal genomes, so no consequence appears. Above some proportion the buffering fails and dysfunction emerges relatively abruptly. This threshold behaviour is characteristic of mitochondrial genetics and has no clean nuclear equivalent.

The functional correlation

Tian and colleagues reported in Aging Cell in 2021 that mitochondrial DNA copy number and heteroplasmy load correlate with skeletal muscle oxidative capacity, measured by phosphorus-31 magnetic resonance spectroscopy. That method assesses muscle energetics non-invasively in living participants, which is a considerably stronger design than inferring function from a tissue sample.

Why this frames the MOTS-c literature

MOTS-c is encoded in that genome and its reported effects concern skeletal muscle metabolism. Copy number and heteroplasmy both vary between people and both track muscle oxidative capacity, so the genomic context this peptide comes from is itself variable. That is relevant background to any measurement of circulating levels between individuals.

Where the measurement gets difficult

Soltész and colleagues examined mtDNA copy number changes, heteroplasmy and mutations across plasma-derived material and tissue in Molecular and Cellular Probes in 2022. Sampling matters: what is measured in circulation need not reflect what is present in a tissue, which is a general caution for any mitochondrial marker measured in blood.

Frequently asked questions

How many mitochondrial genomes does a cell have?

Hundreds to thousands, varying by tissue according to energy demand, not the two copies of a nuclear gene.

What is heteroplasmy?

A mixture of different mitochondrial DNA sequences within one cell, expressed as a proportion rather than present or absent.

Why do threshold effects occur?

Remaining normal genomes buffer a low proportion of a damaging variant. Above some proportion the buffering fails and dysfunction appears relatively abruptly.

Continue researching

Related guides and reference material.

Primary sources & clinical trials

Published papers, trial registrations, regulator pages and company announcements. Links open the original.

UKP

Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).

Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.

Corrections log

More MOTS-c (Mitochondrial Peptide) articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.